Effect of chronic hCG administration on Alzheimer's-related cognition and Aβ accumulation in PS1KI mice

Endocrinology

Volumn 151, Issue 11, 2010, Pages 5380-5388

  Barron, A M ^a,b   Verdile, G ^a,b   Taddei, K ^a,b   Bates, K A ^a,b   Martins, Ralph N ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b EDITH COWAN UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; CHORIONIC GONADOTROPIN; LUTEINIZING HORMONE; PRESENILIN 1; AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; BEHAVIOR DISORDER; COGNITION; CONTROLLED STUDY; EXPERIMENTAL TEST; FEMALE; FOOD PREFERENCE; HORMONE ACTION; HYPERACTIVITY; MAZE TEST; MEMORY DISORDER; MOUSE; NONHUMAN; OPEN FIELD BEHAVIOR; OPEN FIELD TEST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN METABOLISM; PROTEIN PROCESSING; REFERENCE MEMORY; TASTE NEOPHOBIA TEST; WORKING MEMORY; ANALYSIS OF VARIANCE; ANIMAL; BRAIN; CHEMICALLY INDUCED DISORDER; DECISION MAKING; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; HYPERKINESIA; MEMORY; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; TRANSGENIC MOUSE; WESTERN BLOTTING;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANALYSIS OF VARIANCE; ANIMALS; ANXIETY; BLOTTING, WESTERN; BRAIN; CHOICE BEHAVIOR; CHORIONIC GONADOTROPIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; HYPERKINESIS; MAZE LEARNING; MEMORY; MICE; MICE, TRANSGENIC; PRESENILIN-1;

EID: 78049506745     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2009-1168     Document Type: Article

References (56)

1. Brett M, Baxendale S 2001 Motherhood and memory: a review. Psychoneuroendocrinol 26:339-362
2. Rofe Y, Blittner M, Lewin I 1993 Emotional experiences during the three trimesters of pregnancy. J Clin Psychol 49:3-12
3. Bowen RL, Isley JP, Atkinson RL 2000 An association of elevated serum gonadotropin concentrations and Alzheimer disease? J Neuroendocrinol 12:351-354
4. Bowen RL, Smith MA, Harris PLR, Kubat Z, Martins RN, Castellani RJ, Perry G, Atwood CS 2002 Elevated luteinizing hormone expression colocalizes with neurons vulnerable to Alzheimer's disease pathology. J Neurosci Res 70:514-518 (Pubitemid 35222388)
5. Short RA, Bowen RL, O'Brien PC, Graff-Radford NR 2001 Elevated gonadotropin levels in patients with Alzheimer disease. Mayo Clin Proc 76:906-909
6. Barron A, Verdile G, Martins RN 2006 The role of gonadotropins in Alzheimer's disease: Potential neurodegenerative mechanisms. Endocrine 29:257-270
7. Casadesus G, Webber KM, Atwood CS, Pappolla MA, Perry G, Bowen RL, Smith MA 2006 Luteinizing hormone modulates cognition and amyloid-[beta] deposition in Alzheimer APP transgenic mice. Biochim Biophys Acta Mol Basis Dis 1762:447-452 (Pubitemid 43344306)
8. Casadesus G, Milliken EL, Webber KM, Bowen RL, Lei Z, Rao CV, Perry G, Keri RA, Smith MA 2007 Increases in luteinizing hormone are associated with declines in cognitive performance. Mol Cell Endocrinol 269:107-111 (Pubitemid 46483837)
9. Levin-Allerhand JA, Lominska CE, Wang J, Smith JD 2002 17α- estradiol and 17β-estradiol treatments are effective in lowering cerebral amyloid-beta levels in AbetaPPSWE transgenic mice. J Alzheimers Dis 4:449-457 (Pubitemid 36142834)
10. Heikkinen T, Kalesnykas G, Rissanen A, Tapiola T, Iivonen S, Wang J, Chaudhuri J, Tanila H, Miettinen R, Puolivali J 2004 Estrogen treatment improves spatial learning in APP+PS1 mice but does not affect beta amyloid accumulation and plaque formation. Exp Neurol 187:105-117
11. Green PS, Bales K, Paul S, Bu G 2005 Estrogen therapy fails to alter amyloid deposition in the PDAPP model of Alzheimer's disease. Endocrinology 146:2774-2781
12. Levin-Allerhand J, Smith J 2002 Ovariectomy of young mutant amyloid precursor protein transgenic mice leads to increased mortality. J Mol Neurosci 19:163-166 (Pubitemid 35013350)
13. Zheng H, Xu H, Uljon SN, Gross R, Hardy K, Gaynor J, Lafrancois J, Simpkins J, Refolo LM, Petanceska S, Wang R, Duff K 2002 Modulation of Aβ peptides by estrogen in mouse models. J Neurochem 80:191
14. Golub MS, Germann SL, Mercer M, Gordon MN, Morgan DG, Mayer LP, Hoyer PB 2007 Behavioral consequences of ovarian atrophy and estrogen replacement in the APPswe mouse. Neurobiol Aging 29:1512-1523
15. Barron AM, Cake M, Verdile G, Martins RN 2009 Ovariectomy and 17{beta}-estradiol replacement do not alter {beta}-amyloid levels in sheep brain. Endocrinology 150:3228-3236
16. Guo Q, Fu W, Sopher BL, Miller MW, Ware CB, Martin GM, Mattson MP 1999 Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-1 mutant knock-in mice. Nat Med 5:101-106 (Pubitemid 29051006)
17. Duff K, Eckman C, Zehr C, Yu X, Prada C-M, Perez-tur J, Hutton M, Buee L, Harigaya Y, Yager D, Morgan D, Gordon MN, Holcomb L, Refolo L, Zenk B, Hardy J, Younkin S 1996 Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1. Nature 383:710-713.
18. Wang R, Dineley KT, Sweatt JD, Zheng H 2004 Presenilin 1 familial Alzheimer's disease mutation leads to defective associative learning and impaired adult neurogenesis. Neurosci 126:305-312 (Pubitemid 38780806)
19. Parkening TA, Collins TJ, Smith ER 1982 Plasma and pituitary concentrations of luteinizing hormone, follicle-stimulating hormone and prolactin in aged, ovariectomized CD-1 and C57BL/6 mice. Exp Gerontol 17:437-443
20. Batrinos ML, Panitsa-Faflia C, Pitoulis S, Pavlou S, Piaditis G, Alexandridis T 1979 Pituitary hormonal profile in menopause. Maturitas 1:235-245
21. Matt DW, Kauma SW, Pincus SM, Veldhuis JD, Evans WS 1998 Characteristics of luteinizing hormone secretion in younger versus older premenopausal women. Am J Obstet Gynecol 178:504-510
22. Molnar G, Kassai-Bazsa Z 1997 Gonadotropin, ACTH, prolactin, sexual steroid and cortisol levels in postmenopausal women's cerebrospinal fluid (CSF). Arch Gerontol Geriatr 24:269-280 (Pubitemid 27182402)
23. Flurkey K, Gee DM, Sinha YN, Wisner Jr JR, Finch CE 1982 Age effects on luteinizing hormone, progesterone and prolactin in proestrous and acyclic C57BL/6j mice. Biol Reprod 26:835-846 (Pubitemid 12024255)
24. Kovacic N, Parlow AF 1972 Alterations in serum FSH/LH ratios in relation to the estrous cycle, pseudopregnancy, and gonadectomy in the mouse. Endocrinology 91:910-915
25. Hall CS 1936 Emotional behavior in the rat. III. The relationship between emotionality and ambulatory activity. J Comp Psychol 22: 345-352
26. Lukacs H, Hiatt ES, Lei ZM, Rao CV 1995 Peripheral and intracerebroventricular administration of human chorionic gonadotropin alters several hippocampus-associated behaviors in cycling female rats. Horm Behav 29:42-58
27. Ohl F 2003 Testing for anxiety. Clin Neurosci Res 3:233-238
28. Jankowsky JL, Melnikova T, Fadale DJ, Xu GM, Slunt HH, Gonzales V, Younkin LH, Younkin SG, Borchelt DR, Savonenko AV 2005 Environmental enrichment mitigates cognitive deficits in a mouse model of Alzheimer's disease. J Neurosci 25:5217-5224
29. Martins RN, Taddei K, Kendall C, Evin G, Bates KA, Harvey AR 2001 Altered expression of apolipoprotein E, amyloid precursor protein and presenilin-1 is associated with chronic reactive gliosis in rat cortical tissue. Neurosci 106:557-569
30. Mehta PD, Dalton AJ, Mehta SP, Kim KS, Sersen EA, Wisniewski HM 1998 Increased plasma amyloid-β protein 1-42 levels in Down syndrome. Neurosci Lett 241:13-16
31. Mehta P, Mehta S, Sersen E, Aisen P, Wisniewski H 2000 Plasma and cerebrospinal fluid levels of amyloid beta proteins 1-40 and 1-42 in Alzheimer disease. Arch Neurol 57:100-105 (Pubitemid 30027637)
32. Moron I, Gallo M 2007 Effect of previous taste experiences on taste neophobia in young-adult and aged rats. Physiol Behav 90:308-317 (Pubitemid 46177101)
33. Berry A, Tomidokoro Y, Ghiso J, Thornton J 2008 Human chorionic gonadotropin (a luteinizing hormone homologue) decreases spatial memory and increases brain amyloid-β levels in female rats. Horm Behav 54:143-152
34. Toth P, Lukacs H, Hiatt ES, Reid KH, Iyer V, Rao CV 1994 Administration of human chorionic gonadotropin affects sleep-wake phases and other associated behaviors in cycling female rats. Brain Res 654:181-190 (Pubitemid 24245434)
35. Telegdy G, Roszsahegyi G 1971 Effect of gonadotropins on extinction of an avoidance conditioned reflex and exploratory behaviour in the rat. Acta Physiol Hung 40:209-214
36. Palmer K, Berger A-K, Monastero R, Backman L, Winblad B, Fratiglioni L 2006 Anxiety and depressive symptoms as predictors of progression from mild cognitive impairment to Alzheimer's disease. Alzheimers Dement 2:S288
37. Perry RJ, Hodges JR 1999 Attention and executive deficits in Alzheimer's disease. A critical review. Brain 122:383-404
38. Lalonde R, Lewis TL, Strazielle C, Kim H, Fukuchi K 2003 Transgenic mice expressing the βAPP695SWE mutation: effects on exploratory activity, anxiety, and motor coordination. Brain Res 977: 38-45 (Pubitemid 36638692)
39. Ognibene E, Middei S, Daniele S, Adriani W, Ghirardi O, Caprioli A, Laviola G 2005 Aspects of spatial memory and behavioral disinhibition in Tg2576 transgenic mice as a model of Alzheimer's disease. Behav Brain Res 156:225-232
40. Gil-Bea FJ, Aisa B, Schliebs R, Ramirez MJ 2007 Increase of Locomotor Activity Underlying the Behavioral Disinhibition in Tg2576 Mice. Behav Neurosci 121:340-344
41. Zhuo J-M, Prescott SL, Murray ME, Zhang H-Y, Baxter MG, Nicolle MM 2007 Early discrimination reversal learning impairment and preserved spatial learning in a longitudinal study of Tg2576 APPsw mice. Neurobiol Aging 28:1248-1257
42. King DL, Arendash GW 2002 Behavioral characterization of the Tg2576 transgenic model of Alzheimer's disease through 19 months. Physiol Behav 75:627-642 (Pubitemid 34521825)
43. Lalonde R, Kim HD, Fukuchi K 2004 Exploratory activity, anxiety, and motor coordination in bigenic APPswe + PS1/ΔE9 mice. Neurosci Lett 369:156-161 (Pubitemid 39265419)
44. Pugh PL, Richardson JC, Bate ST, Upton N, Sunter D 2007 Non-cognitive behaviours in an APP/PS1 transgenic model of Alzheimer's disease. Behav Brain Res 178:18-28
45. Denk F, Wade-Martins R 2009 Knock-out and transgenic mouse models of tauopathies. Neurobiol Aging 30:1-13
46. Chung JA, Cummings JL 2000 Nurobehavioral and neuropsychiatric symptoms in Alzheimer's disease: characteristics and treatment. Neurologic Clinics 18:829-846 (Pubitemid 32042598)
47. Daffner KR, Scinto LFM, Weintraub S, Guinessey JE, Mesulam MM 1992 Diminished curiosity in patients with probable Alzheimer's disease as measured by exploratory eye movements. Neurol 42: 320-328
48. Baddeley AD, Baddeley HA, Bucks RS, Wilcock GK 2001 Attentional control in Alzheimer's disease. Brain 124:1492-1508
49. Binetti G, Magni E, Padovani A, Cappa SF, Bianchetti A, Trabucchi M 1996 Executive dysfunction in early Alzheimer's disease. J Neurol Neurosurg Psychiatry 60:91-93 (Pubitemid 26012274)
50. Arnáiz E, Almkvist O 2003 Neuropsychological features of mild cognitive impairment and preclinical Alzheimer's disease. Acta Neurologica Scandinavica 107:34-41
51. Duke LM, Kaszniak AW 2000 Executive control functions in degenerative dementias: a comparative review. Neuropsychol Rev 10: 75-99
52. Leonard LG 1998 Depression and anxiety disorders during multiple pregnancy and parenthood. J Obstet Gynecol Neonatal Nurs 27: 329-337
53. Stuart S, Couser G, Schilder K, O'hara MW, Gorman L 1998 Postpartum anxiety and depression: onset and comorbidity in a community sample. J Nerv Ment Dis 186:420-424
54. Grahn JA, Parkinson JA, Owen AM 2008 The cognitive functions of the caudate nucleus. Prog Neurobiol 86:141-155
55. Bowen RL, Verdile G, Liu TB, Parlow AF, Perry G, Smith MA, Martins RN, Atwood CS 2004 Luteinizing hormone, a reproductive regulator that modulates the processing of amyloid-beta precursor protein and amyloid-beta deposition. J Biol Chem 279:20539-20545
56. Lei Z, Rao C, Kornyei J, Licht P, Hiatt E 1993 Novel expression of human chorionic gonadotropin/luteinizing hormone receptor gene in brain. Endocrinology 132:2262-2270 (Pubitemid 23133280)